http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016099774-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08eb5754be4a36234a7f74d588e6930b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00648
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00791
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00797
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-327
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1492
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B90-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-12
filingDate 2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9361292669e3b9f1359dae9d4843f3ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1b4049b0041662e232524b3e4102df5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6258efe6fec399aa2050fc9fc7436796
publicationDate 2016-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016099774-A1
titleOfInvention Timed energy delivery
abstract A method and system for mapping tissue and producing lesions for the treatment of cardiac arrhythmias in a non-thermal and optimal manner, minimizing the amount of energy required to selectively stun or ablate the target tissues. Energy may be delivered only at the moment(s) of best device position and proximity of an electrode to target tissue, and only during a time in the cardiac cycle determined to be optimal for reversible or irreversible effects. A method may include determining timing of the cardiac cycle and an optimal time within the cardiac cycle for energy delivery, evaluating proximity between at least one energy delivery electrode and the target tissue, and delivering pulsed field energy from the at least one energy delivery electrode to the target tissue when, during the optimal time for energy delivery, the at least one energy delivery electrode is in close proximity with the target tissue.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2551140-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2551140-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786300-B2
priorityDate 2014-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0189329-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013030430-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008312673-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008281312-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686

Total number of triples: 42.